Circulating tumor cells (CTCs) shed from primary and metastatic cancers are admixed with
blood components and are thus rare, making their isolation and characterization a major …

Circulating tumor cells (CTCs) in the blood stream play a critical role in establishing
metastases. The clinical value of CTCs as a biomarker for early cancer detection, diagnosis …

Abstract Background Circulating tumor cells (CTCs) have been shown to predict reduced
survival outcomes in metastatic breast cancer. Methods CTCs were analyzed in 2026 …

Purpose: Although unequivocal evidence has shown the prognostic relevance of circulating
tumor cells (CTC) in the peripheral blood of patients with metastatic breast cancer, less …

Purpose: The prognostic value of circulating tumor cells (CTC) detected in breast cancer
patients is currently under debate. Different time points of blood collections and various CTC …

Dispersion of tumors throughout the body is a neoplastic process responsible for the vast
majority of deaths from cancer. Despite disseminating to distant organs as malignant scouts …

The higher incidence of breast cancer in developed countries has been tempered by
reductions in mortality, largely attributable to mammographic screening programmes and …

Epithelial-to-mesenchymal transition (EMT) phenomena endow epithelial cells with
enhanced migratory and invasive potential, and as such, have been implicated in many …

Abstract Background Circulating tumor cells (CTCs) have long been considered a reflection
of tumor aggressiveness. Hematogenous spreading of CTCs from a primary tumor is a …

Circulating tumor cells (CTCs) are important targets for study as we strive to better
understand, diagnose, and treat cancers. However, CTCs are found in blood at extremely …